Publications by authors named "Dadi Zeng"

Claim this Profile
I
IL-11/IL-11R signal inhibition by 9MW3811 remodels immune tumor microenvironment and enhances anti-tumor efficacy of PD-1 blockade.
Chang Zhang, Shasha Jiao, Dadi Zeng, Wen Jiang, Rongjuan Wang

NPJ Precis Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV.
Wen Jiang, Junchao Wang, Shasha Jiao, Chenjian Gu, Wei Xu, Dadi Zeng

MAbs· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan.
Weiyi Qiu, Chang Zhang, Shuang Wang, Xiaoyan Yu, Qiong Wang, Dadi Zeng

J Immunol Res· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel fully human anti-CD47 antibody as a potential therapy for human neoplasms with good safety.
Xiao-Yan Yu, Wei-Yi Qiu, Feng Long, Xiao-Peng Yang, Chang Zhang, Da-di Zeng

Biochimie· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fully human anti-CD47 blocking antibody with therapeutic potential for cancer.
Dadi Zeng, Qiang Sun, Ang Chen, Jiangfeng Fan, Xiaopeng Yang

Oncotarget· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fully human monoclonal antibody with novel binding epitope and excellent neutralizing activity to multiple human IFN-α subtypes: A candidate therapy for systemic lupus erythematosus.
Peng Du, Lei Xu, Weiyi Qiu, Dadi Zeng, Junjie Yue

MAbs· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a novel cell-based assay for screening small molecule antagonists of human interleukin-6 receptor.
Yang-yang He, Yu Yan, Chang Zhang, Peng-yuan Li, Ping Wu, Da-di Zeng

Acta Pharmacol Sin· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing stability of antibody via antibody engineering: stability engineering on an anti-hVEGF.
Shuang Wang, Ming Liu, Dadi Zeng, Weiyi Qiu, Pingping Ma

Proteins· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis